# Tracy MacNeal

> Tracy MacNeal is a chemical engineer turned healthcare executive who serves as President and CEO of Materna Medical, a women's health technology company in Mountain View, California. With more than 25 years across pharmaceuticals, diagnostics, digital health and medical devices, and six transactions to her name, she has built a career on commercializing hard-to-define products and opening markets that others overlook. She sits on the board of AdvaMed and chairs its Women's Executive Network, and she is known for pairing engineering rigor with a storyteller's instinct for building trust with clinicians, investors and customers.

- **Role:** President and CEO at Materna Medical
- **Organizations:** Materna Medical, AdvaMed, Ximedica, ATW Companies, Merck & Co.
- **Nationality:** American
- **Education:** BE, Chemical Engineering, The Cooper Union, MBA, Duke University, Fuqua School of Business
- **Known for:** Leads Materna Medical, a Series B women's health technology company that has raised roughly $82.6M in total funding, More than 25 years across pharmaceuticals, diagnostics, digital health and medical devices, Six successful transactions across her medtech career

## Career timeline

- **1997-2001** — New Product Analyst and Process Engineer at Merck & Co., living and working in New York City and London
- **2011-2017** — Chief Strategy Officer and EVP Sales & Marketing at ATW Companies
- **2017-2019** — President (Diagnostics & Digital Health) and Chief Marketing Officer at Ximedica
- **2019-present** — President and CEO at Materna Medical

## Achievements

- Leads Materna Medical, a Series B women's health technology company that has raised roughly $82.6M in total funding
- More than 25 years across pharmaceuticals, diagnostics, digital health and medical devices
- Six successful transactions across her medtech career
- Board Member at AdvaMed and Chair of its Women's Executive Network
- Built commercialization strategy for products in undefined, first-mover markets

## Latest updates

- **2026-07** — Materna Medical closed additional Series B funding, bringing total funding to roughly $82.6M.
- **2026-06** — Featured in BioTalent's MedTech Spotlight as President and CEO of Materna Medical.

## Links

- Website: https://maternamed.com
- LinkedIn: http://www.linkedin.com/in/tracymacneal
- Twitter/X: https://x.com/tracymacneal
- YouTube: https://www.youtube.com/watch?v=1YIfCBayVAA

---

Profile page: https://yespress.io/tracy-macneal
Published by YesPress — https://yespress.io
Last updated: 2026-07-24